Levomilnacipran Hydrochloride
盐酸左米那普仑
Report date: 2025/12/02 20:00:12
NME
Base Information
Drug NameLevomilnacipran Hydrochloride
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2013/07/25
Country/Territory +[14]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesForest Laboratories Inc
China Registration ClassN/A
Develop Information
Active CompaniesAbbvie IncZhejiang Huahai Pharmaceutical Co Ltd
Inactive CompaniesForest Laboratories IncPierre Fabre Medicament
Active Indications
Inactive Indications